This reduction of expression at day 19, and the increase of expression after 26 days, can be an indication of differentiation into GCs in AD-MSCs which may indicate the presence of early GCs in the treatment groups after 26 days as the OCT4 is highly expressed in early GCs. This evidence concerns the gene POU5F1 and Alzheimer disease.